Clinical Trials Browser

Phase 1/2 × Advanced KRAS G12D Mutant Solid Tumors × Pemetrexed × Clear all

NCT06385678 2025-09-19

A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Phase 1/2 Active not recruiting

Other solid neoplasm

Advanced KRAS G12D Mutant Solid Tumors